Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (2528)	10/12/2018 6:14:16 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3559

Good question, I wouldn't have noticed. Guess you ask an orthopedist/neurologist? A couple of the secondary objectives are interesting. Seem sort of out of blue. Plus, the first two.... how often do we see objectives from a phase II that are the primary objectives of a major phase III program. >> Willing to discontinue current pain medications and to adhere to study requirements for rescue treatments << No, no, no, no, no! May bleed out some day, but I'm not giving up nsaids for more than 48 hrs. Guess I need to wait, no trial for this knee!